The opportunity
Teva’s US Biosimilar business unit has 4 approved biosimilars and plans to launch 5 by 2027. The department is expected to contribute more than $1B in cumulative revenue by 2030. We are searching for a high energy, self-motivated individual that is looking to build a department. This individual will help create future biosimilar market strategy by helping to building creative operational delivery systems for Teva’s biosimilars. Examples include private label operations, co-manufacturing, off shore transfers and TPIG collaboration. In addition, this person will be the point person for biosimilar business development opportunities, working closely with the Business Development department. This person will have an immediate impact on our productivity by streamlining strategic initiatives, overseeing program management, and communicating objectives to our teams. The ideal candidate needs to have proven success in cross functional departments within the pharmaceutical industry. Currently there is one direct report, however the opportunity exists to build a team based on strategic decisions and workload associated with building the department.
This Senior Director must have strong relationships and communication skills as they will interact with senior leaders within the organization engaging in a variety of Teva-specific and industry-related topics.
How you’ll spend your day
Assist in translating strategic goals into actionable plans and initiatives
Develop and implement strategic plans for biosimilar products, including market assessment, competitive analysis, pricing strategy, and market access
Assist with in-depth market research to identify trends, opportunities, and challenges in the biosimilar landscape. Analyze market dynamics, customer needs, and regulatory requirements to inform strategic decision-making
Stay updated on regulatory guidelines and requirements related to biosimilars. Ensure compliance with regulatory standards and guidelines in all strategic initiatives and activities
Collaborate closely with cross-functional teams, including R&D, regulatory affairs, marketing, sales, and finance, to drive alignment and execution of biosimilar strategy initiatives
Monitor competitor activities and industry trends to identify potential threats and opportunities. Develop strategies to maintain competitive advantage in the biosimilar market
Build and maintain relationships with key stakeholders, including healthcare professionals, payers, policymakers, and patient advocacy groups. Represent the company in external meetings, conferences, and industry events
Provide strategic input and support for the commercialization of biosimilar products, including launch planning, market access, and promotional activities
Assess risks associated with biosimilar strategy initiatives and develop mitigation plans to address potential challenges
Collaboration with Business Development department to assess additional biosimilars for the US Market
